Novavax slid nearly 20% in morning trading as the company was facing issues with the purity of its vaccine candidate<blockquote>Novavax 在早盘交易中下跌近 20%,因为该公司面临候选疫苗纯度问题</blockquote>
Novavax slid nearly 20% in morning trading as the company was facing issues with the purity of its v